Publications

464 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:
  1. Advice - Extension of reimbursement conditions for risdiplam (Evrysdi®)

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to also reimburse risdiplam ...

    Report | 20-12-2023

  2. Package advice on the lock procedure medicinal product abemaciclib (Verzenios®) for the treatment of breast cancer

    The National Health Care Institute has assessed whether the medicinal product abemaciclib (Verzenios®) can be reimbursed as an ...

    Report | 13-12-2023

  3. Package advice for the lock procedure for evinacumab (Evkeeza®) for the treatment of a rare form of elevated cholesterol

    The National Health Care Institute has assessed whether the medicinal product evinacumab (Evkeeza®) can be reimbursed from the ...

    Report | 13-12-2023

  4. GVS advice tezepelumab (Tezspire®) for the treatment of patients 12 years and older with severe asthma

    The National Health Care Institute has assessed whether tezepelumab (Tezspire®) can be included in the Medicine Reimbursement ...

    Report | 12-12-2023

  5. Package advice for the lock procedure medicinal product ravulizumab (Ultomiris®) for the treatment of adult patients with myasthenia gravis

    The National Health Care Institute has assessed whether the medicinal product ravulizumab (Ultomiris®) can be reimbursed from the ...

    Report | 12-12-2023

  6. Advice - Extension of reimbursement conditions for lumacaftor/ivacaftor (Orkambi®)

    The National Health Care Institute has investigated whether the reimbursement conditions of lumacaftor in combination with ...

    Report | 11-12-2023

  7. GVS advice empagliflozin (Jardiance®) expansion List 2 conditions for chronic kidney disease

    The National Health Care Institute has assessed whether the reimbursement conditions for empagliflozin (Jardiance®) can be ...

    Report | 07-12-2023

  8. Monitoring the vitamin D package measure

    The Minister of Health, Welfare and Sport (VWS) decided to discontinue the reimbursement of all vitamin D products containing ...

    Report | 01-12-2023

  9. Update advice on the lock procedure for the medicinal product atidarsagene autotemcel (Libmeldy®) for the treatment of metachromatic leukodystrophy (MLD)

    The National Health Care Institute advises the Minister of Health, Welfare and Sport (VWS) to renegotiate the price of ...

    Report | 01-12-2023

  10. Final report – Case study phase ROR DGM

    The Dutch National Health Care Institute presents its vision on data availability in healthcare, based on 4 completed case ...

    Report | 30-11-2023